Written by Jeff Galvin, CEO of American Gene Technologies The birth of high-value therapeutics and cures Does the development of effective drugs have to be incredibly expensive? Maybe not anymore. There is a new type of drug development emerging: Gene Therapy. The hallmark of gene therapy is the ability to edit or modify the drivers of disease at the most fundamental… [Read More]
Contributing Author John Vandermosten, Senior Biotechnology Analyst Examining events of the past can give us a sense of what to expect in the periods ahead. And despite the omnipresent warning that “past performance is not indicative of future results” we will share some historical trends on biotech performance surrounding economic contractions that may prove useful in the current environment. The pandemic… [Read More]
Subscribe to our newsletter to keep up to date with all the latest news about AGT!